MktsMarkets

Tango Therapeutics, Inc.
NASDAQ: TNGXKey statistics
TNGX News
Stories mentioning TNGX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 0.00 | 53,811 | 3,181 | 5,392 | 4,116 | 11,607 | 19,875 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 33,534 | 32,101 | 30,815 | 32,807 | 36,442 | 33,936 | 33,263 | 38,654 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 48,769 | 41,864 | 39,739 | 44,148 | 47,922 | 45,026 | 44,485 | 49,427 |
| Operating Income (Loss) | (48,769) | (41,864) | 14,072 | (40,967) | (42,530) | (40,910) | (32,878) | (29,552) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 1,079 | 1,380 | 705.00 | 910.00 | 1,074 | 1,476 | 1,956 | 1,995 |
| Pretax Income | (45,513) | (38,804) | 15,874 | (38,818) | (39,842) | (37,621) | (29,113) | (25,486) |
| Tax Provision | 1.00 | (55.00) | (10.00) | 35.00 | 34.00 | 49.00 | 54.00 | 65.00 |
| Net Income (Loss) | (45,514) | (38,749) | 15,884 | (38,853) | (39,876) | (37,670) | (29,167) | (25,551) |
| Earnings Per Share (Basic) | (0.32) | (0.33) | 0.14 | (0.35) | (0.36) | (0.34) | (0.27) | (0.24) |
| Earnings Per Share (Diluted) | (0.32) | (0.33) | 0.13 | (0.35) | (0.36) | (0.34) | (0.27) | (0.24) |
| Weighted Average Shares Outstanding (Basic) | 143,576 | 116,166 | 110,966 | 110,541 | 110,301 | 109,227 | 108,507 | 108,314 |
| Weighted Average Shares Outstanding (Diluted) | 143,576 | 116,166 | 117,782 | 110,541 | 110,301 | 109,227 | 108,507 | 108,314 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About TNGX
Tango Therapeutics, Inc. (NASDAQ: TNGX) is a stock listed on the Nasdaq Stock Market under the ticker symbol TNGX. It last traded at $24.70 (Nov 12, 2026, 12:59 PM ET), down 4.0% on the day. That gives Tango Therapeutics a market capitalisation of $4.4B.
Over the past 52 weeks TNGX has traded between $7.49 and $34.39.
Revenue for the quarter ended Mar 31, 2026 was $0; a net loss of $45.5M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $0 | -$45.5M | — |
| Dec 31, 2025 | $0 | -$38.7M | — |
| Sep 30, 2025 | $53.8M | $15.9M | 29.5% |
| Jun 30, 2025 | $3.2M | -$38.9M | -1221.4% |
From Tango Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…